Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Tang, Li Chen ^a   Jin, Xi ^a   Yang, Hai Yuan ^a   He, Min ^a   Chang, Helena ^b   Shao, Zhi Ming ^a   Di, Gen Hong ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Characteristics; Subtype; Survival; Young age

Indexed keywords

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHINA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; LUMINAL A BREAST CANCER; LUMINAL B SUBTYPE BREAST CANCER; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREDICTIVE VALUE; RISK ASSESSMENT; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; TRIPLE NEGATIVE BREAST CANCER; AGED; BREAST NEOPLASMS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; VERY ELDERLY; YOUNG ADULT;

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHINA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; YOUNG ADULT;

EID: 84926315260     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1207-z     Document Type: Article

References (25)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9-29.
2. Surveillance, Epidemiology, and End Results Program. SEER*Stat Database: Incidence- SEER 17 Regs Public Use, Nov. 2008 Sub (2000-2006)-Linked to County Attributes-Total US, 1969-2006 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2009. Released April 2009 based on the November 2008 submission. Available at: www.seer.cancer.gov.
3. Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, et al. Breast cancer in China. Lancet Oncol. 2014;15(7):e279-89.
4. Han W, Kim SW, Park IA, Kang D, Kim SW, Youn YK, et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer. 2004;4:82.
5. Dubsky PC, Gnant MF, Taucher S, Roka S, Kandioler D, Pichler-Gebhard B, et al. Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer. Clin Breast Cancer. 2002;3(1):65-72.
6. Maggard MA, O'Connell JB, Lane KE, Liu JH, Etzioni DA, Ko CY. Do young breast cancer patients have worse outcomes? J Surg Res. 2003;113(1):109-13.
7. Tang LC, Yin WJ, Di GH, Shen ZZ, Shao ZM. Unfavourable clinicopathologic features and low response rate to systemic adjuvant therapy: results with regard to poor survival in young Chinese breast cancer patients. Breast Cancer Res Treat. 2010;122(1):95-104.
8. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin. 2006;56(1):37-47. quiz 50-31.
9. Connolly JL. Changes and problematic areas in interpretation of the AJCC Cancer Staging Manual, 6th Edition, for breast cancer. Arch Pathol Lab Med. 2006;130(3):287-91.
10. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat. 2006;100(2):229-35.
11. Hayes DF, Ethier S, Lippman ME. New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK. Breast Cancer Res Treat. 2006;100(2):237-8.
12. Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, et al. Very young women (<35years) with operable breast cancer: features of disease at presentation. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2002;13(2):273-9.
13. Moon EK, Park HJ, Oh CM, Jung KW, Shin HY, Park BK, et al. Cancer incidence and survival among adolescents and young adults in Korea. PLoS One. 2014;9(5):e96088.
14. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2013;24(9):2206-23.
15. Gajdos C, Tartter PI, Bleiweiss IJ, Bodian C, Brower ST. Stage 0 to stage III breast cancer in young women. J Am Coll Surg. 2000;190(5):523-9.
16. Miles RC, Gullerud RE, Lohse CM, Jakub JW, Degnim AC, Boughey JC. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age. Ann Surg Oncol. 2012;19(4):1153-9.
17. Litiere S, Werutsky G, Fentiman IS, Rutgers E, Christiaens MR, Van Limbergen E, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412-9.
18. Wei XQ, Li X, Xin XJ, Tong ZS, Zhang S. Clinical features and survival analysis of very young (age<35) breast cancer patients. Asian Pacific journal of cancer prevention: APJCP. 2013;14(10):5949-52.
19. Molino A, Giovannini M, Auriemma A, Fiorio E, Mercanti A, Mandara M, et al. Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol Hematol. 2006;59(3):226-33.
20. Tang J, Wu CC, Xie ZM, Luo RZ, Yang MT. Comparison of Clinical Features and Treatment Outcome of Breast Cancers in Young and Elderly Chinese Patients. Breast care. 2011;6(6):435-40.
21. R. Prati YF, D.U. Chang, M.K. Lee, S. Apple, S.A. Huryitz, H. Chang: Effect of young age on aggressive subtypes of breast cancer (BC). SSO, Abstract 2092063, March 25-28, 2015. 2015.
22. Lin CH, Chuang PY, Chiang CJ, Lu YS, Cheng AL, Kuo WH, et al. Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study. Oncologist. 2014;19(6):583-91.
23. Horn J, Opdahl S, Engstrom MJ, Romundstad PR, Tretli S, Haugen OA, et al. Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women. Cancer causes control: CCC. 2014;25(7):881-9.
24. Bayraktar S, Amendola L, Gutierrez-Barrera AM, Hashmi SS, Amos C, Gambello M, et al. Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35years of age or less. Breast. 2014;23(6):770-4.
25. Robson M, Gilewski T, Haas B, Levin D, Borgen P, Rajan P, et al. BRCA-associated breast cancer in young women. J Clin Oncol Off J Am Soc Clin Oncol. 1998;16(5):1642-9.